CKD Worldwide: Rising Cases Reach 788 Million Adults
Okay, here’s a breakdown of the provided text, summarizing the key findings of the study on Chronic Kidney Disease (CKD):
Key Findings of the Global CKD Study (2023 Data):
* Rising Prevalence: Global CKD prevalence reached 14.2% in 2023, a 3.5% increase as 1990. Most cases are mild to moderate (stages 1-3, 13.9% prevalence).
* Regional Disparities: North Africa adn the Middle east have the highest burden of CKD (18% of adults affected). This is linked to rising metabolic, lifestyle, and environmental risk factors.
* Significant Mortality: CKD is the 9th leading cause of death worldwide, responsible for 1.48 million deaths in 2023.
* Disease Burden: CKD ranks 12th globally in Disability-Adjusted Life Years (DALYs), with rates of 769 per 100,000 adults.
* Cardiovascular Link: CKD is a major amplifier of cardiovascular risk. Impaired kidney function accounts for 11.5% of global cardiovascular deaths. Improving CKD recognition and treatment could reduce cardiac mortality.
* Comprehensive Assessment: The study is the most comprehensive global assessment of CKD to date, using data from 204 countries and territories.
Methodology:
The researchers used published literature, vital registration systems, kidney failure registries, and household surveys to generate updated estimates for prevalence, incidence, deaths, DALYs, and the proportion of cardiovascular mortality attributable to impaired kidney function.
Call to Action:
The study calls for coordinated international action to address the rising burden of CKD.
In essence, the study highlights that CKD is a growing global health problem with significant consequences for both individual health and overall mortality rates, particularly in relation to cardiovascular disease.